---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-023705"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2026-06-02T20:05:29+00:00"
generated_at: "2026-06-02T20:12:54.903913+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics annual meeting results: all proposals pass including election of two Class I directors

## Summary
- Alison C. Finger elected as Class I director with 156.8M for, 19.4M withheld, 23.0M broker non-votes.
- Eduardo Rene Salas elected with 172.0M for, 4.3M withheld, 23.0M broker non-votes.
- Ratification of KPMG as auditor for FY2026 approved: 198.7M for, 0.33M against, 0.28M abstain.
- Non-binding Say-on-Pay proposal approved with 168.2M for, 7.7M against, 0.33M abstain, 23.0M broker non-votes.

## SEC filing metadata
- accession: 0001140361-26-023705
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2026-06-02T20:05:29+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/0001140361-26-023705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/ef20075432_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-023705
- JSON: https://secwatch.observer/filing/0001140361-26-023705.json
- Plain text: https://secwatch.observer/filing/0001140361-26-023705.txt

## Key facts
- Shareholder Votes
  ADMA BIOLOGICS, INC. shareholders approved Election of two nominees to serve as Class I directors until the Company's 2029 Annual Meeting of Stockholders and until such director's successor is duly elected and qualified, or such director's earlier resignation, removal or death at the 2026-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: Proposal No. 1 — Election of the Class I Directors The vote with respect to the election of each of the directors was as follows: Nominee For Withheld Broker Non-Votes Alison C. Finger 156,849,830 19,376,842 23,040,875 Eduardo Rene Salas 171,947,523 Shares 4,279,149 Shares 23,040,875 Shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/0001140361-26-023705-index.htm
- Shareholder Votes
  ADMA BIOLOGICS, INC. shareholders approved Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers at the 2026-06-02 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: Proposal No. 3 — Approval of the Say-on-Pay Proposal The vote with respect to the approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers was as follows: For Against Abstain Broker Non-Votes 168,169,866 Shares 7,730,690 Shares 326,116 Shares 23,040,875 Shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/0001140361-26-023705-index.htm
- Shareholder Votes
  ADMA BIOLOGICS, INC. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: For Against Abstain 198,655,040 Shares 329,056 Shares 283,451 Shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1368514/000114036126023705/0001140361-26-023705-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.